Potential for use sunitinib in pancreatic neuroendocrine tumors

Potential for use sunitinib in pancreatic neuroendocrine tumors

The treatment efficacy and toxicity profile was evaluated in 33 patients with highly differentiated neuroendocrine tumors NEO (G1, G2), who received sunitinib therapy in various dose regimens. Stable disease was achieved in 24 patients (72.7%), partial effect in 1 patient (3%). The efficacy of treat...

Full description

Saved in:
Bibliographic Details
Published in:Medicinskij sovet no. 10; pp. 115 - 119
Main Authors: Markovich, A. A., Kuznetsova, A. A., Gorbunova, V. A., Orel, N. F., Odintsova, A. S., Emelyanova, G. S., Kuzminov, A. E.
Format: Journal Article
Language:English
Russian
Published: Remedium Group LLC 24-06-2019
Subjects:
neuroendocrine tumors
safety profile
sunitinib
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The treatment efficacy and toxicity profile was evaluated in 33 patients with highly differentiated neuroendocrine tumors NEO (G1, G2), who received sunitinib therapy in various dose regimens. Stable disease was achieved in 24 patients (72.7%), partial effect in 1 patient (3%). The efficacy of treatment did not depend on the used dose regimen. The toxicity profile was consistent with international study data.
ISSN:2079-701X
2658-5790
DOI:10.21518/2079-701X-2019-10-115-119